Vyvanse Capsules Specified Drug Use-results Survey (Surveillance regarding pediatric long-term use)
Not Applicable
- Conditions
- Attention deficit/hyperactivity disorder
- Registration Number
- JPRN-UMIN000039018
- Lead Sponsor
- Takeda Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 1820
Inclusion Criteria
Not provided
Exclusion Criteria
NA
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method (1) Safety Incidence rates of adverse drug reactions, Safety specification items of Vyvanse Capsules (2) Efficacy Evaluation of physicians by the ADHD Rating Scale IV (ADHD RS-IV) Japanese Version
- Secondary Outcome Measures
Name Time Method